Hims & Hers: There's Opportunity In This Crash (Upgrade)

Gary Alexander
32.4K Followers

Summary

  • Hims & Hers offers a compelling "Buy" opportunity after a 30% pullback, despite recent growth concerns and insider selling.
  • HIMS maintains strong long-term growth targets, aiming for $6.5 billion in revenue and $1.3+ billion in adjusted EBITDA by FY30 (representing ~4x profit expansion from current levels).
  • Current valuation appears more attractive, with HIMS trading at 32.8x EV/FY25 adjusted EBITDA and potentially 24.7x by FY26.
  • Expansion into new markets and specialties, including hormone health and longevity, supports the bullish outlook for HIMS.
Many different pills on pink background. Prescription pills and vitamins. Flat lay and space for text.

Baurzhan Ibrashev/iStock via Getty Images

With the S&P 500 continuing to scrape toward new heights, it has become an incredibly tough stock market to invest in. That said, the increased volatility in trading over the past several weeks has created a tremendous opportunity to buy selective dips in

Create a free account to read the full article

Gain access to the world's leading investment community.

Already registered?

By creating an account using any of the options above, you agree to the Terms of Use & Privacy Policy
or

About HIMS Stock

SymbolLast Price% Chg
HIMS
47.44-0.04%
Chart
Combination chart with 2 data series.
The chart has 1 X axis displaying Time. Data ranges from 2025-10-20 09:30:00 to 2025-10-23 11:50:00.
The chart has 1 Y axis displaying values. Data ranges from 46.435 to 51.94.
End of interactive chart.
Market Cap
$10.73B
PE (FWD)
81.28
Yield
-
Rev Growth (YoY)
88.69%
Short Interest
32.63%
Prev. Close
$47.46